Profile data is unavailable for this security.
About the company
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
- Revenue in USD (TTM)326.24m
- Net income in USD15.30m
- Incorporated1986
- Employees1.06k
- LocationSTAAR Surgical Co1911 Walker AveMONROVIA 91016United StatesUSA
- Phone+1 (626) 303-7902
- Fax+1 (302) 636-5454
- Websitehttps://www.staar.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Owens & Minor, Inc. | 10.42bn | -38.77m | 1.41bn | 13.70k | -- | 1.57 | 5.58 | 0.1349 | -0.5099 | -0.5099 | 136.98 | 11.71 | 1.98 | 6.79 | 14.60 | 760,861.20 | -0.7372 | 1.32 | -1.11 | 2.07 | 20.75 | 16.48 | -0.3719 | 0.5614 | 0.5648 | 2.19 | 0.7065 | 0.798 | 3.80 | 1.87 | -284.47 | -- | 25.91 | -- |
Inmode Ltd | 466.26m | 181.11m | 1.55bn | 581.00 | 8.72 | 1.86 | 8.55 | 3.33 | 2.11 | 2.11 | 5.42 | 9.87 | 0.5973 | 1.71 | 16.09 | 802,509.40 | 23.20 | 31.32 | 25.21 | 35.64 | 83.10 | 84.46 | 38.84 | 39.65 | 12.66 | -- | 0.00 | 0.00 | 8.32 | 37.49 | 22.54 | 54.65 | 13.10 | -- |
Establishment Labs Holdings Inc | 155.79m | -82.76m | 1.56bn | 908.00 | -- | 27.44 | -- | 10.02 | -3.15 | -3.15 | 5.90 | 2.07 | 0.6095 | 0.9191 | 3.39 | 171,579.30 | -32.38 | -33.22 | -39.25 | -41.12 | 65.01 | 64.73 | -53.12 | -43.19 | 2.73 | -10.80 | 0.7715 | -- | 2.13 | 21.96 | -4.38 | -- | 69.16 | -- |
Alphatec Holdings Inc | 511.63m | -191.60m | 1.59bn | 839.00 | -- | 43.01 | -- | 3.10 | -1.49 | -1.49 | 3.97 | 0.4294 | 0.7612 | 1.34 | 6.70 | 609,808.10 | -28.51 | -30.97 | -37.13 | -39.47 | 65.89 | 66.02 | -37.45 | -46.22 | 1.49 | -5.17 | 0.8938 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
LeMaitre Vascular Inc | 199.89m | 33.95m | 1.71bn | 614.00 | 50.35 | 5.50 | 39.22 | 8.53 | 1.51 | 1.51 | 8.89 | 13.81 | 0.5977 | 1.17 | 7.19 | 325,548.90 | 10.15 | 9.02 | 10.99 | 9.93 | 66.45 | 65.83 | 16.99 | 15.45 | 5.31 | -- | -- | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
Warby Parker Inc | 697.80m | -55.06m | 1.74bn | 2.14k | -- | 5.51 | -- | 2.50 | -0.4646 | -0.4646 | 5.73 | 2.66 | 1.21 | 5.19 | 655.52 | 326,074.80 | -9.57 | -- | -11.95 | -- | 55.01 | 57.49 | -7.89 | -14.53 | 2.02 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
UFP Technologies Inc | 407.33m | 47.88m | 2.01bn | 3.09k | 42.11 | 6.80 | 33.70 | 4.92 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1033 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
Premier Inc | 1.34bn | 80.33m | 2.07bn | 2.80k | 30.78 | 1.08 | 10.52 | 1.55 | 0.6421 | 0.6421 | 11.34 | 18.35 | 0.3887 | 5.25 | 3.10 | 477,306.10 | 1.89 | 10.39 | 2.48 | 13.00 | 66.20 | 62.04 | 4.87 | 22.60 | 0.8226 | 143.62 | 0.276 | 19.11 | -6.76 | 2.44 | -34.17 | -15.30 | -2.29 | -- |
STAAR Surgical Co | 326.24m | 15.30m | 2.11bn | 1.06k | 138.56 | 5.36 | 101.74 | 6.45 | 0.3093 | 0.3093 | 6.62 | 8.00 | 0.7159 | 2.11 | 5.09 | 308,942.30 | 3.36 | 6.77 | 3.82 | 7.90 | 78.51 | 76.89 | 4.69 | 9.16 | 5.22 | -- | 0.0004 | 0.00 | 13.37 | 21.07 | -46.18 | 33.85 | 51.95 | -- |
Conmed Corp | 1.26bn | 82.35m | 2.17bn | 4.00k | 26.83 | 2.53 | 14.04 | 1.72 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Patterson Companies, Inc. | 6.57bn | 193.86m | 2.36bn | 7.60k | 12.97 | 2.44 | 8.41 | 0.3588 | 2.03 | 2.03 | 68.86 | 10.78 | 2.23 | 5.61 | 14.48 | 864,047.90 | 6.58 | 0.3702 | 11.30 | 0.5655 | 21.30 | 21.05 | 2.95 | 0.1811 | 0.7243 | 12.08 | 0.4462 | 846.10 | -0.4298 | 3.44 | 2.14 | 10.79 | 8.22 | 0.00 |
Helen of Troy Limited | 2.01bn | 168.59m | 2.44bn | 1.93k | 14.51 | 1.48 | 11.06 | 1.21 | 7.05 | 7.05 | 83.65 | 68.94 | 0.6971 | 2.48 | 5.19 | 1,040,503.00 | 5.86 | 7.69 | 6.90 | 9.53 | 47.31 | 44.32 | 8.41 | 9.24 | 0.9936 | 5.27 | 0.289 | -- | -3.26 | 5.09 | 17.67 | -0.6548 | 6.79 | -- |
Inari Medical Inc | 520.66m | -23.62m | 2.47bn | 1.30k | -- | 5.51 | -- | 4.74 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
ICU Medical Inc | 2.26bn | -59.31m | 2.59bn | 14.00k | -- | 1.25 | 15.22 | 1.15 | -2.46 | -2.46 | 93.27 | 84.87 | 0.5154 | 2.12 | 15.86 | 161,223.70 | -1.35 | 1.46 | -1.51 | 1.65 | 32.48 | 34.11 | -2.63 | 2.23 | 1.09 | 0.4817 | 0.4393 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
Enovis Corp | 1.82bn | -103.33m | 2.80bn | 6.55k | -- | 0.8462 | 20.64 | 1.54 | -1.89 | -1.50 | 33.29 | 60.33 | 0.3717 | 1.49 | 5.49 | 277,452.20 | -2.10 | -0.3569 | -2.32 | -0.41 | 58.12 | 48.19 | -5.66 | -1.06 | 1.03 | 0.9243 | 0.2879 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
Tandem Diabetes Care Inc | 770.01m | -141.45m | 2.85bn | 2.40k | -- | 11.70 | -- | 3.69 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
Holder | Shares | % Held |
---|---|---|
Broadwood Capital, Inc.as of 31 Dec 2023 | 10.54m | 21.57% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 7.25m | 14.83% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 5.33m | 10.91% |
Baillie Gifford & Co.as of 31 Mar 2024 | 4.11m | 8.42% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 1.93m | 3.96% |
Jackson Square Partners LLCas of 31 Dec 2023 | 1.69m | 3.47% |
Palo Alto Investors LPas of 31 Dec 2023 | 1.38m | 2.82% |
Geode Capital Management LLCas of 31 Dec 2023 | 1.06m | 2.17% |
Defender Capital LLCas of 31 Dec 2023 | 722.53k | 1.48% |
Geneva Capital Management LLCas of 31 Mar 2024 | 711.19k | 1.46% |